Literature DB >> 1753394

A scheme for the identification of viridans streptococci.

D Beighton1, J M Hardie, R A Whiley.   

Abstract

A collection of strains representing all the currently recognised species of oral or viridans streptococci (Streptococcus sanguis, S. parasanguis, S. gordonii, S. oralis, S. mitis, S. salivarius, S. vestibularis, S. anginosus, S. constellatus, s. intermedius, S. mutans and S. sobrinus) were tested for the production of a range of glycosidase activities with 4-methylumbelliferyl-linked fluorogenic substrates, and for reactions in a range of conventional fermentation and hydrolytic tests. The resulting biochemical scheme, consisting of 14 tests, enabled the differentiation of all these species and distinguished three biotypes within S. sanguis. The scheme reported here represents an improvement over currently available schemes for the identification of viridans streptococci.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1753394     DOI： 10.1099/00222615-35-6-367

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  57 in total

1.  PCR-Based methods for genotyping viridans group streptococci.

Authors:  S Alam; S R Brailsford; R A Whiley; D Beighton
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Description and evaluation of the semiautomated 4-hour rapid ID 32 Strep method for identification of streptococci and members of related genera.

Authors:  J Freney; S Bland; J Etienne; M Desmonceaux; J M Boeufgras; J Fleurette
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

3.  Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region.

Authors:  Chao Chien Chen; Lee Jene Teng; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory.

Authors:  P P Bosshard; S Abels; M Altwegg; E C Böttger; R Zbinden
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

5.  Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.

Authors:  F C Pimenta; E N Miyaji; A P M Arêas; M L S Oliveira; A L S S de Andrade; P L Ho; S K Hollingshead; L C C Leite
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

6.  Array-based identification of species of the genera Abiotrophia, Enterococcus, Granulicatella, and Streptococcus.

Authors:  Sheng Kai Tung; Lee Jene Teng; Mario Vaneechoutte; Hung Mo Chen; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

7.  Streptococcus mutans, Streptococcus sobrinus and Candida albicans in oral samples from caries-free and caries-active children.

Authors:  S Fragkou; C Balasouli; O Tsuzukibashi; A Argyropoulou; G Menexes; N Kotsanos; S Kalfas
Journal:  Eur Arch Paediatr Dent       Date:  2016-06-29

8.  Identification of clinically relevant viridans streptococci by an oligonucleotide array.

Authors:  Chao Chien Chen; Lee Jene Teng; Seng Kaiung; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

9.  Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.

Authors:  Eiman M Mokaddas; Nathaneal O Salako; Leeba Philip; Vincent O Rotimi
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

10.  Comparison of lysis filtration and an automated blood culture system (BACTEC) for detection, quantification, and identification of odontogenic bacteremia in children.

Authors:  Victoria S Lucas; Vasiliki Lytra; Thoraya Hassan; Helen Tatham; M Wilson; Graham J Roberts
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.